|
|
Featured Media Release
14 May 2013 - GSK Australia Reports 2012 Results to ASIC
GlaxoSmithKline (GSK) reported to the Australian Securities and Investment Commission (ASIC) for 2012 sales of $1,452m and a total profit before tax of $41m.
|
| |
Media Releases
 |
Wake up your whole mouth – with new Macleans® Protect Lemonmint
New Macleans Protect Lemonmint has a refreshing twist of lemon, which leaves the mouth feeling clean and energised after brushing. Best of all, Macleans Protect Lemonmint is also a great family toothpaste, that helps to maintain strong teeth,... |
08/12/2006 |
|
 |
GlaxoSmithKline scientists will provide biomedical research students and fellows, with an insight on career options.
GlaxoSmithKline scientists will provide biomedical research students and fellows, with an insight on the career options available to them in the pharmaceutical industry on November 26, 2006. |
09/11/2006 |
|
 |
Smile, with new Macleans® White & Shine!
Macleans White & Shine is an exciting new toothpaste that whitens and polishes your teeth as you brush, leaving your teeth not only white but so smooth they shine! |
08/11/2006 |
|
 |
Happy birthday, Glaxo!
From milk to medicines, Glaxo has been a recognised name for 100 years. |
31/10/2006 |
|
 |
Polident Fresh Cleanse® – A Breakthrough in Denture Cleansing and Freshening
Introducing Polident fresh cleanse, a unique foaming antibacterial denture cleanser. When you pump Polident fresh cleanse onto your denture, the minty liquid transforms into active foam. With brushing, it microcleans away tough stains and kills... |
23/10/2006 |
|
 |
Tackling the 'Looming Crisis' in Science Education
The Monash Science Centre and GlaxoSmithKline are working together to address the serious decline in science education participation by running a novel program for school age children. |
06/09/2006 |
|
 |
Alzheimer’s disease better understood due to genetic research
Poor glucose utilisation, commonly associated with type 2 diabetes, plays a role in Alzheimer’s disease and researchers are now investigating whether medicines for diabetes may be effective in treating the degenerative brain disease. |
10/08/2006 |
|
 |
Physeptone 10mg tablets supply recommencing
GlaxoSmithKline Australia (GSKA) is pleased to advise that we have resolved the supply issue regarding Physeptone 10mg tablets and that by Friday 2nd June they will be available from pharmacies as per normal. |
28/05/2006 |
|
 |
Supply of Physeptone 10mg tablets
GSK has experienced difficulties with the supply of a raw material that has stopped the manufacture of Physeptone 10mg tablets. Physeptone is used for the relief of chronic pain. We estimate this may affect about 7,000 patients across Australia. |
18/05/2006 |
|
 |
The GlaxoSmithKline Australia Award For Research Excellence.
Australian research is increasing our understanding of cardiovascular disease, the leading cause of premature death in Australia following the identification of key 'master regulator' genes (such as EGR-1) by Professor Levon Khachigian which control... |
19/04/2006 |
|
 |
 |